OMEPRAZOLE
| Brand name | OMEPRAZOLE |
|---|---|
| Active ingredient | OMEPRAZOLE |
| Strength | 20MG |
| Dosage form | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2017 |
| Marketing status | OTC |
| Patent | Expires | Type |
|---|---|---|
| 10835488 | December 2036 | product |
| 10076494 | December 2036 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.